Gino Santini
Director/Board Member at COLLEGIUM PHARMACEUTICAL, INC.
Net worth: 3 M $ as of 2024-04-29
Profile
Gino Santini's current jobs include being a Director at ImClone LLC since 2008, a Lead Independent Director at Collegium Pharmaceutical, Inc. since 2012, a Director at Artax Biopharma, Inc. since 2014, a Director at Intarcia Therapeutics, Inc. since 2013, and an Independent Director at Enalare Therapeutics, Inc. .
His former jobs include being the Chairman at National Pharmaceutical Council, the Chairman at AMAG Pharmaceuticals, Inc. from 2014 to 2020, the Chairman at Noble of Indiana, the Lead Independent Director at Intercept Pharmaceuticals, Inc. from 2018 to 2023, an Independent Director at Inspiration Biopharmaceuticals, Inc., an Independent Director at Horizon Therapeutics Plc from 2012 to 2023, an Independent Director at Sorin SpA from 2012 to 2015, an Independent Director at Vitae Pharmaceuticals LLC from 2015 to 2016, a Director at Greater Indianapolis Chamber of Commerce, Inc., a Director at United Way of Central Indiana, Inc., a Director at Indiana Chamber of Commerce, a Director at Finanziaria Saccarifera Italo Iberica.
SpA from 2013 to 2014, an Independent Director at Horizon Pharma, Inc. from 2012 to 2014, a Director at Allena Pharmaceuticals, Inc. from 2012 to 2022, and an SVP-Corporate Strategy & Business Development at Eli Lilly & Co. from 2008 to 2010.
Mr. Santini's education includes an undergraduate degree from Alma Mater Studiorum - Università di Bologna in 1981, an undergraduate degree from Università di Bologna Buenos Aires in 1981, and an MBA from the University of Rochester Simon Business School in 1983.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-05-15 | 75,656 ( 0.24% ) | 3 M $ | 2024-04-29 |
Gino Santini active positions
Companies | Position | Start |
---|---|---|
COLLEGIUM PHARMACEUTICAL, INC. | Director/Board Member | 2012-07-23 |
Enalare Therapeutics, Inc.
Enalare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enalare Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies for patients with life-threatening acute respiratory and critical care conditions, such as community drug overdose, post-operative respiratory depression, and apnea of prematurity. Enalare Therapeutics is based in Princeton, NJ. Enalare maintains rights to its novel compounds and intends to start additional clinical trials with ena-001 for several indications in the near term. The company was founded by Joseph V. Pergolizzi and is currently led by CEO Herm Cukier. | Director/Board Member | - |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | Director/Board Member | 2015-03-31 |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Director/Board Member | 2013-07-25 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Director/Board Member | 2008-11-20 |
Former positions of Gino Santini
Companies | Position | End |
---|---|---|
INTERCEPT PHARMACEUTICALS, INC. | Director/Board Member | 2023-11-07 |
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Director/Board Member | 2023-10-05 |
ALLENA PHARMACEUTICALS, INC. | Director/Board Member | 2022-09-01 |
AMAG PHARMACEUTICALS, INC. | Chairman | 2020-11-15 |
░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Gino Santini
Alma Mater Studiorum - Università di Bologna | Undergraduate Degree |
Università di Bologna Buenos Aires | Undergraduate Degree |
University of Rochester Simon Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
ALLENA PHARMACEUTICALS, INC. | Health Technology |
Private companies | 19 |
---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | Health Technology |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | Health Technology |
Horizon Therapeutics Plc
Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Sorin SpA
Sorin SpA Medical SpecialtiesHealth Technology Sorin SpA engages in the research, development, and manufacture of technology products for the treatment of cardiovascular diseases. It operates through the Cardiac Surgery and Cardiac Rhythm business segments. The Cardiac Surgery segment involves in the production and marketing of single-use biomedical devices, systems used to ensure out-of-body circulation in cardiac surgical procedures, and implantable prosthetics to replace or repair heart valves. The Cardiac Rhythm segment deals with the production and marketing of implantable devices and monitoring equipment and accessories to protect against heartbeat disorders. The company was founded in 1956 and is headquartered in Milan, Italy. | Health Technology |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Health Technology |
Vitae Pharmaceuticals LLC
Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
Greater Indianapolis Chamber of Commerce, Inc.
Greater Indianapolis Chamber of Commerce, Inc. Miscellaneous Commercial ServicesCommercial Services Greater Indianapolis Chamber of Commerce, Inc. operates as a chamber of commerce. It specializes in talent attraction, economic development, entrepreneur services, business advocacy, events, and membership. The company is headquartered in Indianapolis, IN. | Commercial Services |
United Way of Central Indiana, Inc.
United Way of Central Indiana, Inc. Services to the Health IndustryHealth Services United Way of Central Indiana, Inc. provides social services. The firm specializes in health, financial stability, community impact, live united, basic needs and connecting resources. The company was founded in 1986 and is headquartered in Indianapolis, IN. | Health Services |
National Pharmaceutical Council
National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Commercial Services |
Indiana Chamber of Commerce
Indiana Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Indiana Chamber of Commerce operates as business advocacy organization. The firm provides economic opportunity and prosperity for the people of Indiana and their enterprises. It offers health care savings, employment posters and office solutions. The company was founded in 1922 and is headquartered in Indianapolis, IN. | Commercial Services |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Noble of Indiana
Noble of Indiana Miscellaneous Commercial ServicesCommercial Services Noble of Indiana operates as an organization for disabled care services. The non-profit company is based in Indianapolis, IN. | Commercial Services |
Eli Lilly y CIA de México SA de CV | |
Horizon Pharma, Inc.
Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Horizon Pharma, Inc. discovers and develops medicines for the treatment of chronic inflammatory diseases. It is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company products include DUEXIS (ibuprofen and famotidine) Tablets, is a proprietary, single-tablet combination of the non-steroidal anti-inflammatory drug ibuprofen and the histamine H2-receptor antagonist famotidine; RAYOS (prednisone) delayed-release tablets, known as LODOTRA outside the U.S., is a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe, active RA in adults, particularly when accompanied by morning stiffness. Horizon Pharma was founded on March 23, 2010 and is headquartered in Deerfield, IL. | Health Technology |
United Way of The Lewis & Clark | |
Prime Movers Lab LLC
Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | Finance |
Enalare Therapeutics, Inc.
Enalare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enalare Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies for patients with life-threatening acute respiratory and critical care conditions, such as community drug overdose, post-operative respiratory depression, and apnea of prematurity. Enalare Therapeutics is based in Princeton, NJ. Enalare maintains rights to its novel compounds and intends to start additional clinical trials with ena-001 for several indications in the near term. The company was founded by Joseph V. Pergolizzi and is currently led by CEO Herm Cukier. | Commercial Services |
Finanziaria Saccarifera Italo Iberica SpA
Finanziaria Saccarifera Italo Iberica SpA Real Estate DevelopmentFinance Part of Societe Generale De Partecipations Agro-Alimentaires SA, Finanziaria Saccarifera Italo Iberica SpA operates as a real estate agency. The company is based in Cesena, Italy. | Finance |
- Stock Market
- Insiders
- Gino Santini